Purchase of a new Autoclave

The Food and Drug Administration is preparing to purchase a new autoclave to replace an outdated model that is no longer manufactured and for which service and parts are unavailable, posing a significant safety concern. The acquisition is necessary to maintain critical sterilization capabilities essential for operational integrity and compliance with public health standards. The procurement is forecasted under NAICS code 541990, indicating it falls within other scientific and technical consulting services, though the specific nature of the requirement relates directly to equipment replacement for laboratory and facility safety. There is no set-aside designation, and the place of performance and office address details have not been specified, suggesting the project may be executed at an FDA facility yet to be identified. The point of contact for program inquiries is the Hfp Acquisition Liaison, reachable via hfpacquisitions@fda.hhs.gov, while the contracting officer position is currently vacant and will be assigned prior to formal solicitation. The forecast was posted on May 25, 2026, and the opportunity can be viewed on the HHS OSDBU website.